Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Xenetic Biosciences
(NASDAQ:XBIO)
Intraday
$3.75
-0.01
[-0.27%]
After-Hours
$3.75
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.75
-0.01
[-0.27%]
At close: Mar 28
$3.75
0
[0.00%]
After Hours: 6:57PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Xenetic Biosciences Stock (NASDAQ:XBIO)
Xenetic Biosciences Stock (NASDAQ: XBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 25, 2024
CORRECTION: On Friday, Xenetic Biosciences Q4 GAAP EPS $(0.77) Beats $(0.87) Estimate, Sales $671.96K Miss $680.00K Estimate
Benzinga Newsdesk
-
Mar 25, 2024, 6:59AM
Wednesday, January 17, 2024
Xenetic Biosciences Enters Into Research Agreement With University Of Virginia For Advancement Of DNase-Based Oncology Platform
Benzinga Newsdesk
-
Jan 17, 2024, 9:05AM
Tuesday, December 05, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Dec 5, 2023, 12:31PM
Friday, November 10, 2023
Xenetic Biosciences: Q3 Earnings Insights
Benzinga Insights
-
Nov 10, 2023, 9:10AM
Xenetic Biosciences Q3 EPS $(0.69) Beats $(1.12) Estimate, Sales $611.17K Beat $460.00K Estimate
Benzinga Newsdesk
-
Nov 10, 2023, 8:44AM
Friday, August 11, 2023
Xenetic Biosciences Reports Q2 Net Loss $(1.1)M, Cash Balance of $10.7M
Benzinga Newsdesk
-
Aug 11, 2023, 8:13AM
Tuesday, June 20, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jun 20, 2023, 9:13AM
Tuesday, May 16, 2023
Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences
Vandana Singh
-
May 16, 2023, 2:55PM
HC Wainwright & Co. Downgrades Xenetic Biosciences to Neutral
Benzinga Newsdesk
-
May 16, 2023, 6:27AM
Monday, May 15, 2023
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
May 15, 2023, 1:45PM
Friday, May 12, 2023
Xenetic Biosciences shares are trading lower after the company announced a 1-for-10 reverse stock split.
Benzinga Newsdesk
-
May 12, 2023, 2:37PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
May 12, 2023, 1:31PM
Xenetic Biosciences, Inc. Announces 1-For-10 Reverse Stock Split Of Common Stock
Happy Mohamed
-
May 12, 2023, 12:33PM
Thursday, April 13, 2023
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
-
Apr 13, 2023, 2:54PM
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh
-
Apr 13, 2023, 7:38AM
Wednesday, April 12, 2023
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh
-
Apr 12, 2023, 9:46AM
Tuesday, April 11, 2023
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh
-
Apr 11, 2023, 2:28PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Apr 11, 2023, 9:06AM
Xenetic Biosciences, Inc. Announces Research And Development Collaboration With The Scripps Research Institute To Advance DNase Platform
Happy Mohamed
-
Apr 11, 2023, 8:32AM
Thursday, March 16, 2023
US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh
-
Mar 16, 2023, 8:56AM
Thursday, March 02, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Mar 2, 2023, 8:06AM
Wednesday, March 01, 2023
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh
-
Mar 1, 2023, 1:24PM
Monday, February 06, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 6, 2023, 12:31PM
Tuesday, January 17, 2023
Xenetic Biosciences, Inc. Announces Notice Of Allowance For Canadian Patent Covering Use Of DNase Enzyme For Preventing Or Ameliorating Toxicity Associated With Chemotherapy
Benzinga Newsdesk
-
Jan 17, 2023, 8:06AM
Monday, December 19, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 19, 2022, 4:31PM
Friday, December 16, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Dec 16, 2022, 12:39PM
Wednesday, November 30, 2022
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 30, 2022, 8:09AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 30, 2022, 8:09AM
Wednesday, November 16, 2022
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Nov 16, 2022, 2:02PM
Thursday, November 10, 2022
Xenetic Biosciences Says Ended Q3 2022 With $13.8M Of Cash Expected To Fund Operations, Drive Expanded Pipeline
Benzinga Newsdesk
-
Nov 10, 2022, 7:09AM
Friday, October 28, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Oct 28, 2022, 12:12PM
Wednesday, October 12, 2022
Xenetic Biosciences Says Co. Entered Into Subscription Agreement With CLS Therapeutics, Pursuant To Which Co. Agreed To Issue 850K Shares To CLS
Michael Horton
-
Oct 12, 2022, 5:05PM
Tuesday, October 11, 2022
Xenetic Biosciences, Inc. Announces Signing Of Patent Assignment Related To Collaboration With VolitionRx Limited And CLS Therapeutics
Bill Haddad
-
Oct 11, 2022, 8:08AM
Friday, August 12, 2022
Xenetic Biosciences Cash Position $14.9M
Bill Haddad
-
Aug 12, 2022, 8:08AM
Tuesday, August 02, 2022
Xenetic Biosciences, VolitionRx Limited Collaborate To Develop NETs-Targeted Adoptive Cell Therapies For The Treatment Of Cancer
Benzinga Newsdesk
-
Aug 2, 2022, 8:06AM
Wednesday, May 04, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
May 4, 2022, 5:43PM
Monday, May 02, 2022
HC Wainwright & Co. Maintains Buy on Xenetic Biosciences, Lowers Price Target to $4
Benzinga Newsdesk
-
May 2, 2022, 6:08AM
Friday, April 29, 2022
74 Biggest Movers From Yesterday
Lisa Levin
-
Apr 29, 2022, 5:19AM
Thursday, April 28, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Apr 28, 2022, 3:31PM
48 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Apr 28, 2022, 12:05PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Apr 28, 2022, 8:16AM
28 Stocks Moving in Thursday's Pre-Market Session
Lisa Levin
-
Apr 28, 2022, 6:30AM
Wednesday, April 27, 2022
Xenetic Biosciences Enters Exclusive License And Sublicense Agreements With CLS Therapeutics; Xenetic To Make Upfront Payment Of $500K In Cash And Issue 875K Shares Of Common Stock As Well As Up To $13M In Future Milestones
Bill Haddad
-
Apr 27, 2022, 6:45AM
Tuesday, March 08, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Mar 8, 2022, 4:47PM
Wednesday, February 23, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Feb 23, 2022, 4:41PM
Tuesday, January 18, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jan 18, 2022, 10:59AM
Tuesday, January 11, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jan 11, 2022, 8:08AM
Wednesday, December 08, 2021
'We are expanding the potential of CAR T cell therapy through the development of our XCART technology platform...' -Tweet From Xenetic Biosciences
Benzinga Newsdesk
-
Dec 8, 2021, 11:24AM
Monday, November 22, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 22, 2021, 9:06AM
Friday, November 12, 2021
Xenetic Biosciences Q3 2021 Net Loss $(1.4)M
Benzinga Newsdesk
-
Nov 12, 2021, 8:04AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch